Combinations for the treatment of inflammatory disorders
The invention features a pharmaceutical composition that includes amoxapine and a corticosteroid.
1. A pharmaceutical composition formulated for oral, rectal, intravenous, intramuscular, subcutaneous, inhalation, vaginal, or ophthalmic administration, said composition comprising amoxapine and a corticosteroid, wherein the amoxapine and corticosteroid are present in amounts that, when administered together to a patient having an inflammatory disorder, inhibit or reduce inflammation.
2. The composition of claim 1 , wherein amoxapine is present in the composition in an amount of 1-600 milligrams.
3. The composition of claim 2 , wherein amoxapine is present in the composition in an amount of 100-300 milligrams.
4. The composition of claim 1 , wherein the steroid is present in the composition in an amount of 0.05-200 milligrams.
5. The composition of claim 4 , wherein the steroid is present in the composition in an amount of 0.05-5 milligrams.
6. The composition of claim 5 , wherein the steroid is present in the composition in an amount of 0.1-3 milligrams.
7. The composition of claim 1 , wherein the composition is formulated for oral administration.
8. The composition of claim 1 , wherein the composition is formulated for rectal administration.